BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Blaauboer A, Booy S, van Koetsveld PM, Karels B, Dogan F, van Zwienen S, van Eijck CHJ, Hofland LJ. Interferon-beta enhances sensitivity to gemcitabine in pancreatic cancer. BMC Cancer 2020;20:913. [PMID: 32967656 DOI: 10.1186/s12885-020-07420-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Fu H, Xu J, Wang F, Wang W, Kang X, Wang Z. Interferon Beta (IFN-β)-Modified Bone Marrow Mesenchymal Stem Cells (BMSC) Impede Metastatic Tropism of Prostate Cancer via Modulating Transforming Growth Factor-Beta/Smads (TGF-Beta/Smads) Pathway. j biomater tissue eng 2022;12:2106-2112. [DOI: 10.1166/jbt.2022.3152] [Reference Citation Analysis]
2 Ji T, Wu H, Ma K, Zhang Z. Constructing a Novel Prognostic Signature Based on TGF-β Signaling for Personalized Treatment in Pancreatic Adenocarcinoma. Journal of Oncology 2022;2022:1-15. [DOI: 10.1155/2022/4419119] [Reference Citation Analysis]
3 Zhang J, Li R, Huang S. The immunoregulation effect of tumor microenvironment in pancreatic ductal adenocarcinoma. Front Oncol 2022;12:951019. [DOI: 10.3389/fonc.2022.951019] [Reference Citation Analysis]
4 Solomon PE, Kirkemo LL, Wilson GM, Leung KK, Almond MH, Sayles LC, Sweet-Cordero EA, Rosenberg OS, Coon JJ, Wells JA. Discovery Proteomics Analysis Determines That Driver Oncogenes Suppress Antiviral Defense Pathways Through Reduction in Interferon-β Autocrine Stimulation. Mol Cell Proteomics 2022;21:100247. [PMID: 35594991 DOI: 10.1016/j.mcpro.2022.100247] [Reference Citation Analysis]
5 Chen Y, Chen D, Wang Q, Xu Y, Huang X, Haglund F, Su H. Immunological Classification of Pancreatic Carcinomas to Identify Immune Index and Provide a Strategy for Patient Stratification. Front Immunol 2021;12:719105. [PMID: 35111149 DOI: 10.3389/fimmu.2021.719105] [Reference Citation Analysis]
6 Blaauboer A, van Koetsveld PM, Mustafa DAM, Dumas J, Dogan F, van Zwienen S, van Eijck CHJ, Hofland LJ. The Class I HDAC Inhibitor Valproic Acid Strongly Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Immune System Activation. Biomedicines 2022;10:517. [DOI: 10.3390/biomedicines10030517] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Iansante V, Brooks A, Coney L. Considerations in the Design of Non-Clinical Development Programmes to Support Non-Viral Genetically Modified Mesenchymal Stromal Cell Therapies. Pharmaceutics 2021;13:823. [PMID: 34199356 DOI: 10.3390/pharmaceutics13060823] [Reference Citation Analysis]
8 Huang HW, Chang CC, Wang CS, Lin KH. Association between Inflammation and Function of Cell Adhesion Molecules Influence on Gastrointestinal Cancer Development. Cells 2021;10:E67. [PMID: 33406733 DOI: 10.3390/cells10010067] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 11.0] [Reference Citation Analysis]